Even more clinically relevant, there is evidence regarding the potential to integrate blood BDNF levels with Hamilton Depression Rating Scale scores to predict treatment response during the early phases of therapy, prior to observable symptom changes [31]. This evidence concerns the gene BDNF and depressive symptom measurement.